Clinical Trial Update: Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial updates the safety and preliminary activity of decitabine combined with selinexor in patients with relapsed or refractory acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• Selinexor (selinexor)

Snippet

Sponsor: Bhavana Bhatnagar | Conditions: Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED